Tag: needle-free drug delivery devices market size

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theNeedle-Free Drug Delivery Devices Market?

The rising prevalence of diabetes is supporting the needle-free drug delivery device market. Diabetes is increasing due to lifestyle, genetics, and aging populations. Needle-free devices offer alternatives for insulin administration through patches or jet injectors. In June 2024, the NHS reported that 549,000 more individuals were at risk of type 2 diabetes in 2023, raising the total to 3,615,330, a 20% increase from 2022. This rise is driving demand for needle-free solutions.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

How Will the Growth Rate of theNeedle-Free Drug Delivery Devices Market Impact Industry Trends by 2034?

The needle-free drug delivery devices market size has grown rapidly in recent years. It will increase from $16.7 billion in 2024 to $18.67 billion in 2025 at a CAGR of 11.8%. Historic growth contributors include rising chronic disease cases, demand for pain-free delivery systems, an aging population, emphasis on patient compliance, regulatory backing, and pharmaceutical expansion.

The needle-free drug delivery devices market is forecasted to grow to $28.86 billion in 2029, at a CAGR of 11.5%. The growth is driven by the demand for painless medication, patient-centric healthcare, expanding pediatric and geriatric populations, chronic disease prevalence, device innovations, and increased R&D. Trends include wearable devices, microfluidic technology, pediatric-friendly solutions, AI and ML integration, and home healthcare applications.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

What Are the Latest Innovations Influencing theNeedle-Free Drug Delivery Devices Market?

Major companies in the needle-free drug delivery device market are innovating with advanced tools like dual-chamber inhalers to simplify treatment. In April 2024, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler, a dry powder inhaler (DPI) with dual chambers. It features an all-plastic body, dose counter, and a bi-directional mouthpiece, promoting accurate, hygienic, and convenient multi-drug delivery.

Who Are the Major Industry Players Accelerating Growth in theNeedle-Free Drug Delivery Devices Market?

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Which Primary Segments of the Needle-Free Drug Delivery Devices Market Are Driving Growth and Industry Transformations?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)

5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theNeedle-Free Drug Delivery Devices Market?# Market?

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2025, By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theNeedle-Free Drug Delivery Devices Market?

The rising prevalence of diabetes is supporting the needle-free drug delivery device market. Diabetes is increasing due to lifestyle, genetics, and aging populations. Needle-free devices offer alternatives for insulin administration through patches or jet injectors. In June 2024, the NHS reported that 549,000 more individuals were at risk of type 2 diabetes in 2023, raising the total to 3,615,330, a 20% increase from 2022. This rise is driving demand for needle-free solutions.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

How Will the Growth Rate of theNeedle-Free Drug Delivery Devices Market Impact Industry Trends by 2034?

The needle-free drug delivery devices market size has grown rapidly in recent years. It will increase from $16.7 billion in 2024 to $18.67 billion in 2025 at a CAGR of 11.8%. Historic growth contributors include rising chronic disease cases, demand for pain-free delivery systems, an aging population, emphasis on patient compliance, regulatory backing, and pharmaceutical expansion.

The needle-free drug delivery devices market is forecasted to grow to $28.86 billion in 2029, at a CAGR of 11.5%. The growth is driven by the demand for painless medication, patient-centric healthcare, expanding pediatric and geriatric populations, chronic disease prevalence, device innovations, and increased R&D. Trends include wearable devices, microfluidic technology, pediatric-friendly solutions, AI and ML integration, and home healthcare applications.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

What Are the Latest Innovations Influencing theNeedle-Free Drug Delivery Devices Market?

Major companies in the needle-free drug delivery device market are innovating with advanced tools like dual-chamber inhalers to simplify treatment. In April 2024, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler, a dry powder inhaler (DPI) with dual chambers. It features an all-plastic body, dose counter, and a bi-directional mouthpiece, promoting accurate, hygienic, and convenient multi-drug delivery.

Who Are the Major Industry Players Accelerating Growth in theNeedle-Free Drug Delivery Devices Market?

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Which Primary Segments of the Needle-Free Drug Delivery Devices Market Are Driving Growth and Industry Transformations?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)

5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theNeedle-Free Drug Delivery Devices Market?# Market?

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2025, By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Discover trends, market shifts, and competitive outlooks for the needle-free drug delivery devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Needle-Free Drug Delivery Devices Market In 2029?

The market size for needle-free drug delivery devices has seen a significant expansion in recent years. The market, which was worth $16.7 billion in 2024, is expected to rise to $18.67 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this growth during the historical period include a surge in chronic diseases, a growing preference for painless drug delivery systems, an increase in the elderly population, a focus on patient compliance and safety, regulatory encouragement for needle-free technologies, and growth in the pharmaceutical industry.

In the future few years rapid expansion is anticipated in the needle-free drug delivery devices market, with predictions of hitting $28.86 billion by 2029, boasting a compound annual growth rate (CAGR) of 11.5%. This potential growth during the forecast phase is associated with the rising demand for pain-free medication administration, the increased focus on healthcare solutions centered around patient needs, broader usage amongst children and the elderly, the increasing necessity for frequent injections due to a high prevalence of chronic diseases, advancements in technology that improves device performance and accessibility, improved healthcare accessibility in developing markets, and increased funding in research and development for new delivery systems. Projected trends for the forecast period comprise greater acceptance of wearable and connected devices, the introduction of innovative microfluidic technologies, an increasing emphasis on child-friendly needle-free solutions, the incorporation of artificial intelligence and machine learning algorithms, and wider applications in the home healthcare sector.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

Which Primay Drivers Are Accelerating Growth in the Needle-Free Drug Delivery Devices Market?

The escalating incidence of diabetes is anticipated to spur the expansion of the needle-free drug delivery device market in the future. Diabetes, characterized by elevated blood sugar levels, arises from either poor insulin production or inefficient insulin use by the body. Causes for the rise in diabetes include inactive lifestyles, poor dietary habits, a genetic predisposition, urbanization, and aging populations. These are exacerbated by limited health care access and an increase in global obesity rates. Needle-free drug delivery devices offer an alternative to traditional insulin injections in diabetes management. Technologies such as jet injectors or transdermal patches are used, which administer insulin through the skin without using needles. This removes the usual discomfort and anxiety associated with injections and enhances comfort levels. For example, in June 2024, the National Health Service, a UK-based government agency, reported that in 2023 it identified an additional 549,000 individuals in England at risk of developing type 2 diabetes. This increased the total number of people registered with a GP as having non-diabetic hyperglycaemia, or pre-diabetes, to 3,615,330. This marked an almost 20% rise from the previous year’s figure of 3,065,825. Thus, the escalating incidence of diabetes is fueling the growth of the needle-free drug delivery device market.

How Is the Needle-Free Drug Delivery Devices Market Segmented?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)

5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp

Which Regions Are Key Players in the Growth of the Needle-Free Drug Delivery Devices Market?

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Needle-Free Drug Delivery Devices Industry Dynamics?

Key players in the needle-free drug delivery device market, such as dual chamber inhalers, are prioritizing groundbreaking solutions to boost efficiency and ease of application, thus meeting the growing needs of patients and healthcare practitioners. A dual-chamber inhaler is a type of device that houses two separate compartments capable of containing varied medications independently. This design facilitates the integration of several medications into one inhaler, thereby simplifying therapy and enhancing patient convenience. For instance, in April 2024, Berry Global, a renowned US plastic manufacturing firm, unveiled the BerryHaler, an innovative dry powder inhaler (DPI) crafted to radically transform patient-focused healthcare solutions. This dual-chamber inhaler is equipped with a dose counter to ensure accurate drug administration. The completely plastic structure, devoid of any metal components, makes it the perfect choice for intricate inhalation remedies, easing the dosage procedure and effectively accommodating multiple medications. Additional advanced features are a bi-directional mouthpiece cover for ease and sanitation, alongside audible alerts for correct utilization. The embedded dose counter facilities accurate tracking of medication usage, thereby eliminating the possibilities of dosage mishaps.

View the full report here:

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

How Is the Needle-Free Drug Delivery Devices Market Defined and What Are Its Core Parameters?

Needle-free drug delivery devices refer to medical tools designed to administer medication without traditional needles. They offer an alternative means of delivering drugs, vaccines, or therapeutic agents into the body through the skin or mucosal membranes. These devices aim to reduce patient discomfort and the risk of needle-related injuries.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the needle-free drug delivery devices market grown over the years?

There has been a swift increase in the market size of needle-free drug delivery devices in the past few years. Projected to grow from $16.7 billion in 2024 to $18.67 billion in 2025, it boasts a compound annual growth rate (CAGR) of 11.8%. The boost in its growth in the historic period is attributed to various factors such as heightened incidence of chronic ailments, an elevated demand for pain-free methods of drug delivery, increased geriatric population, focus on patient safety and compliance, regulatory encouragement for the development of needle-free technology, and the broadening scale of the pharmaceutical industry.

What Is the forecasted market size and growth rate for the needle-free drug delivery devices market?

Expectations are high for significant expansion in the needle-free drug delivery devices market in the forthcoming years. The market is poised to climb to $28.86 billion in 2029, advancing at a compound annual growth rate (CAGR) of 11.5%. The upswing during this forecast period can be linked to factors such as the escalating demand for pain-free medicine administration, the growing focus on patient-oriented healthcare, broadening utilization in child and elderly patient groups, the increasing incidence of chronic conditions requiring recurring injections, improvements in technology that optimize device effectiveness and user-friendliness, broader access to healthcare in developing markets, and the rise in investment in research and development aimed at innovative delivery systems. Among the dominant trends throughout the forecast period are the swelling adoption of wearable and interconnected devices, the introduction of new microfluidic technologies, an increased emphasis on child-friendly needle-free solutions, the incorporation of artificial intelligence and machine learning algorithms, and the widening application in home healthcare environments.

Get your needle-free drug delivery devices market report here!

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

What are the major factors driving growth in the needle-free drug delivery devices market?

The growth of the needle-free drug delivery device market is anticipated to be driven by the escalating incidence of diabetes. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or ineffective insulin use, is a continuing health concern. Factors such as inactive lifestyle, poor eating habits, genetic factors, urbanization, and aging, along with limited healthcare access and global increase in obesity, contribute to the upsurge of diabetes. Needle-free drug delivery devices, offering an alternative to traditional insulin injections used in diabetes management, are gaining popularity. These devices employ methods such as jet injectors or transdermal patches to transport insulin through the skin sans needles, mitigating injection-associated discomfort and fear and improving comfort. Citing the National Health Service, a government department in the UK, in June 2024, it identified an extra 549,000 individuals in England at risk of developing type 2 diabetes in 2023. This increased the total of persons with non-diabetic hyperglycemia or pre-diabetes registered with a GP to 3,615,330, marking a considerable jump from 3,065,825 in 2022; a nearly 20% increase. Thus, the growing incidence of diabetes contributes to the expansion of the needle-free drug delivery device market.

What key areas define the segmentation of the global needle-free drug delivery devices Market?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)

5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

What are the top market players propelling the growth of the needle-free drug delivery devices industry?

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

Which trends are expected to transform the needle-free drug delivery devices market?

Prominent entities in the needle-free drug delivery device industry are concentrating on advanced options, like dual chamber inhalers, with the intention of boosting the effectiveness and simplicity of administration and addressing the evolving necessities of patients and healthcare professionals. A dual-chamber inhaler is a mechanism with two sections, each capable of containing distinct medications independently. This structure encourages the blending of multiple drugs into a single inhaler, making treatment more efficient and convenient for patients. For example, Berry Global, a plastic manufacturing firm from the US, unveiled the BerryHaler in April 2024. This is a state-of-the-art dry powder inhaler (DPI) constructed to redefine patient-centric health care solutions. The dual-chamber inhaler features a dose counter for accurate medication delivery. It’s made entirely of plastic, with no metal components, and is therefore ideal for intricate inhalation procedures. This simplifies each dosage and facilitates the effective combination of various medications. In addition, it integrates advanced characteristics such as a bi-directional mouthpiece cover for user-friendliness and cleanliness, audible alerts indicating correct usage, and an inbuilt dose counter to keep tabs on medication utilization and avert dosage mishaps.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

What regions are dominating the needle-free drug delivery devices market growth?

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the needle-free drug delivery devices market grown over the years?

There has been a swift increase in the market size of needle-free drug delivery devices in the past few years. Projected to grow from $16.7 billion in 2024 to $18.67 billion in 2025, it boasts a compound annual growth rate (CAGR) of 11.8%. The boost in its growth in the historic period is attributed to various factors such as heightened incidence of chronic ailments, an elevated demand for pain-free methods of drug delivery, increased geriatric population, focus on patient safety and compliance, regulatory encouragement for the development of needle-free technology, and the broadening scale of the pharmaceutical industry.

What Is the forecasted market size and growth rate for the needle-free drug delivery devices market?

Expectations are high for significant expansion in the needle-free drug delivery devices market in the forthcoming years. The market is poised to climb to $28.86 billion in 2029, advancing at a compound annual growth rate (CAGR) of 11.5%. The upswing during this forecast period can be linked to factors such as the escalating demand for pain-free medicine administration, the growing focus on patient-oriented healthcare, broadening utilization in child and elderly patient groups, the increasing incidence of chronic conditions requiring recurring injections, improvements in technology that optimize device effectiveness and user-friendliness, broader access to healthcare in developing markets, and the rise in investment in research and development aimed at innovative delivery systems. Among the dominant trends throughout the forecast period are the swelling adoption of wearable and interconnected devices, the introduction of new microfluidic technologies, an increased emphasis on child-friendly needle-free solutions, the incorporation of artificial intelligence and machine learning algorithms, and the widening application in home healthcare environments.

Get your needle-free drug delivery devices market report here!

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

What are the major factors driving growth in the needle-free drug delivery devices market?

The growth of the needle-free drug delivery device market is anticipated to be driven by the escalating incidence of diabetes. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or ineffective insulin use, is a continuing health concern. Factors such as inactive lifestyle, poor eating habits, genetic factors, urbanization, and aging, along with limited healthcare access and global increase in obesity, contribute to the upsurge of diabetes. Needle-free drug delivery devices, offering an alternative to traditional insulin injections used in diabetes management, are gaining popularity. These devices employ methods such as jet injectors or transdermal patches to transport insulin through the skin sans needles, mitigating injection-associated discomfort and fear and improving comfort. Citing the National Health Service, a government department in the UK, in June 2024, it identified an extra 549,000 individuals in England at risk of developing type 2 diabetes in 2023. This increased the total of persons with non-diabetic hyperglycemia or pre-diabetes registered with a GP to 3,615,330, marking a considerable jump from 3,065,825 in 2022; a nearly 20% increase. Thus, the growing incidence of diabetes contributes to the expansion of the needle-free drug delivery device market.

What key areas define the segmentation of the global needle-free drug delivery devices Market?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)

5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

What are the top market players propelling the growth of the needle-free drug delivery devices industry?

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

Which trends are expected to transform the needle-free drug delivery devices market?

Prominent entities in the needle-free drug delivery device industry are concentrating on advanced options, like dual chamber inhalers, with the intention of boosting the effectiveness and simplicity of administration and addressing the evolving necessities of patients and healthcare professionals. A dual-chamber inhaler is a mechanism with two sections, each capable of containing distinct medications independently. This structure encourages the blending of multiple drugs into a single inhaler, making treatment more efficient and convenient for patients. For example, Berry Global, a plastic manufacturing firm from the US, unveiled the BerryHaler in April 2024. This is a state-of-the-art dry powder inhaler (DPI) constructed to redefine patient-centric health care solutions. The dual-chamber inhaler features a dose counter for accurate medication delivery. It’s made entirely of plastic, with no metal components, and is therefore ideal for intricate inhalation procedures. This simplifies each dosage and facilitates the effective combination of various medications. In addition, it integrates advanced characteristics such as a bi-directional mouthpiece cover for user-friendliness and cleanliness, audible alerts indicating correct usage, and an inbuilt dose counter to keep tabs on medication utilization and avert dosage mishaps.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

What regions are dominating the needle-free drug delivery devices market growth?

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theNeedle-Free Drug Delivery Devices Market?

The rising prevalence of diabetes is supporting the needle-free drug delivery device market. Diabetes is increasing due to lifestyle, genetics, and aging populations. Needle-free devices offer alternatives for insulin administration through patches or jet injectors. In June 2024, the NHS reported that 549,000 more individuals were at risk of type 2 diabetes in 2023, raising the total to 3,615,330, a 20% increase from 2022. This rise is driving demand for needle-free solutions.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

How Will the Growth Rate of theNeedle-Free Drug Delivery Devices Market Impact Industry Trends by 2034?

The needle-free drug delivery devices market size has grown rapidly in recent years. It will increase from $16.7 billion in 2024 to $18.67 billion in 2025 at a CAGR of 11.8%. Historic growth contributors include rising chronic disease cases, demand for pain-free delivery systems, an aging population, emphasis on patient compliance, regulatory backing, and pharmaceutical expansion.

The needle-free drug delivery devices market is forecasted to grow to $28.86 billion in 2029, at a CAGR of 11.5%. The growth is driven by the demand for painless medication, patient-centric healthcare, expanding pediatric and geriatric populations, chronic disease prevalence, device innovations, and increased R&D. Trends include wearable devices, microfluidic technology, pediatric-friendly solutions, AI and ML integration, and home healthcare applications.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

What Are the Latest Innovations Influencing theNeedle-Free Drug Delivery Devices Market?

Major companies in the needle-free drug delivery device market are innovating with advanced tools like dual-chamber inhalers to simplify treatment. In April 2024, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler, a dry powder inhaler (DPI) with dual chambers. It features an all-plastic body, dose counter, and a bi-directional mouthpiece, promoting accurate, hygienic, and convenient multi-drug delivery.

Who Are the Major Industry Players Accelerating Growth in theNeedle-Free Drug Delivery Devices Market?

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Which Primary Segments of the Needle-Free Drug Delivery Devices Market Are Driving Growth and Industry Transformations?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)

5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theNeedle-Free Drug Delivery Devices Market?# Market?

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2025, By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the needle-free drug delivery devices market grown over the years?

There has been a swift increase in the market size of needle-free drug delivery devices in the past few years. Projected to grow from $16.7 billion in 2024 to $18.67 billion in 2025, it boasts a compound annual growth rate (CAGR) of 11.8%. The boost in its growth in the historic period is attributed to various factors such as heightened incidence of chronic ailments, an elevated demand for pain-free methods of drug delivery, increased geriatric population, focus on patient safety and compliance, regulatory encouragement for the development of needle-free technology, and the broadening scale of the pharmaceutical industry.

What Is the forecasted market size and growth rate for the needle-free drug delivery devices market?

Expectations are high for significant expansion in the needle-free drug delivery devices market in the forthcoming years. The market is poised to climb to $28.86 billion in 2029, advancing at a compound annual growth rate (CAGR) of 11.5%. The upswing during this forecast period can be linked to factors such as the escalating demand for pain-free medicine administration, the growing focus on patient-oriented healthcare, broadening utilization in child and elderly patient groups, the increasing incidence of chronic conditions requiring recurring injections, improvements in technology that optimize device effectiveness and user-friendliness, broader access to healthcare in developing markets, and the rise in investment in research and development aimed at innovative delivery systems. Among the dominant trends throughout the forecast period are the swelling adoption of wearable and interconnected devices, the introduction of new microfluidic technologies, an increased emphasis on child-friendly needle-free solutions, the incorporation of artificial intelligence and machine learning algorithms, and the widening application in home healthcare environments.

Get your needle-free drug delivery devices market report here!

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

What are the major factors driving growth in the needle-free drug delivery devices market?

The growth of the needle-free drug delivery device market is anticipated to be driven by the escalating incidence of diabetes. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or ineffective insulin use, is a continuing health concern. Factors such as inactive lifestyle, poor eating habits, genetic factors, urbanization, and aging, along with limited healthcare access and global increase in obesity, contribute to the upsurge of diabetes. Needle-free drug delivery devices, offering an alternative to traditional insulin injections used in diabetes management, are gaining popularity. These devices employ methods such as jet injectors or transdermal patches to transport insulin through the skin sans needles, mitigating injection-associated discomfort and fear and improving comfort. Citing the National Health Service, a government department in the UK, in June 2024, it identified an extra 549,000 individuals in England at risk of developing type 2 diabetes in 2023. This increased the total of persons with non-diabetic hyperglycemia or pre-diabetes registered with a GP to 3,615,330, marking a considerable jump from 3,065,825 in 2022; a nearly 20% increase. Thus, the growing incidence of diabetes contributes to the expansion of the needle-free drug delivery device market.

What key areas define the segmentation of the global needle-free drug delivery devices Market?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)

5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

What are the top market players propelling the growth of the needle-free drug delivery devices industry?

Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

Which trends are expected to transform the needle-free drug delivery devices market?

Prominent entities in the needle-free drug delivery device industry are concentrating on advanced options, like dual chamber inhalers, with the intention of boosting the effectiveness and simplicity of administration and addressing the evolving necessities of patients and healthcare professionals. A dual-chamber inhaler is a mechanism with two sections, each capable of containing distinct medications independently. This structure encourages the blending of multiple drugs into a single inhaler, making treatment more efficient and convenient for patients. For example, Berry Global, a plastic manufacturing firm from the US, unveiled the BerryHaler in April 2024. This is a state-of-the-art dry powder inhaler (DPI) constructed to redefine patient-centric health care solutions. The dual-chamber inhaler features a dose counter for accurate medication delivery. It’s made entirely of plastic, with no metal components, and is therefore ideal for intricate inhalation procedures. This simplifies each dosage and facilitates the effective combination of various medications. In addition, it integrates advanced characteristics such as a bi-directional mouthpiece cover for user-friendliness and cleanliness, audible alerts indicating correct usage, and an inbuilt dose counter to keep tabs on medication utilization and avert dosage mishaps.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

What regions are dominating the needle-free drug delivery devices market growth?

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Needle-Free Drug Delivery Devices Market, and What Are the Key Drivers?

The market of needle-free drug delivery devices has seen a notable rapid enlargement recently. Its size is set to swell from $16.7 billion in 2024 to a staggering $18.67 billion in 2025, boasting an impressive compound annual growth rate (CAGR) of 11.8%. The driving factors behind this historic period of growth include a higher occurrence of chronic diseases, rising demand for non-painful drug delivery methods, a growing elderly population, a focus on patient compliance and safety, regulatory encouragement for needle-free techniques, and an expanding pharmaceutical industry.

The market size for needle-free drug delivery devices is anticipated to experience a significant expansion in the upcoming years, rising to $28.86 billion in 2029 with a compound annual growth rate (CAGR) of 11.5%. The surge during the forecast period can be credited to the rising need for pain-free drug administration, the increasing focus on healthcare solutions centered around the patient, widening usage in pediatric and geriatric groups, an uptick in chronic illnesses requiring regular injections, advancements in technology improving device effectiveness and usability, growing access to healthcare in developing markets, and escalated investment in research and development for novel delivery systems. Key trends to watch in the forecast period include higher uptake of wearable and interconnected devices, the introduction of groundbreaking microfluidic technologies, heightened emphasis on needle-free solutions suitable for children, the incorporation of artificial intelligence and machine learning systems, and broadening applications in domestic healthcare environments.

What Drivers Are Shaping the Growth of the Needle-Free Drug Delivery Devices Market?

The needle-free drug delivery device market’s expansion is likely to be fueled by the growing occurrences of diabetes. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or ineffective use of insulin by the body, is a persistent health problem. The upward trend of diabetes is attributed to inactive lifestyles, poor eating habits, genetic factors, urbanization, and aging populations. Limited healthcare access and escalating obesity rates are also contributing globally. Needle-free drug delivery devices present a substitute to traditional insulin injections in managing diabetes. These devices employ techniques like jet injectors or transdermal patches, enabling insulin to penetrate the skin without the use of needles. This eliminates the discomfort and fear often associated with injections, thereby increasing comfort levels. For instance, in June 2024, as per the UK-based government body, the National Health Service, the NHS identified an additional 549,000 individuals vulnerable to type 2 diabetes in England in 2023. This brought the total number of pre-diabetic individuals registered with a GP to 3,615,330, representing a substantial increase compared to 3,065,825 in 2022, indicating a surge of nearly 20%. Thus, the escalating instances of diabetes is driving the growth of the needle-free drug delivery device market.

Request Your Free Needle-Free Drug Delivery Devices Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

Which Companies Are Leading the Charge in Expanding the Needle-Free Drug Delivery Devices Market?

Major companies operating in the needle-free drug delivery devices market are:

• Pfizer Inc._x000D_

• Merck & Co. Inc._x000D_

• Bayer AG_x000D_

• 3M Company_x000D_

• Medtronic plc_x000D_

What New Trends Are Reshaping the Needle-Free Drug Delivery Devices Market and Its Opportunities?

Key players in the needle-free drug delivery device market are concentrating their efforts on innovative products like dual chamber inhalers to improve efficiency and ease of use, catering to the changing requirements of healthcare providers and patients. These dual-chamber devices have two sections capable of holding separate medications, enabling multiple drugs to be combined within a single inhaler, enhancing treatment delivery and patient convenience. For example, in April 2024, Berry Global, a plastic manufacturing company from the USA, unveiled their product, the BerryHaler. This is an advanced dry powder inhaler (DPI) aimed at transforming patient-focused healthcare solutions. The BerryHaler, a dual-chamber inhaler with a dose counter, ensures exact dispensing of medication. Its all-plastic build, free from any metal components, makes it perfectly suitable for complex inhalation therapies. This design simplifies drug dosage and combination. Other sophisticated features consist of a bi-directional mouthpiece cover for ease and cleanliness and sound signals for correct usage. The built-in dose counter assists in accurate tracking of medication consumption, preventing dosage mishaps.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Needle-Free Drug Delivery Devices Market?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)

5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

What Are the Top Regions Fueling Growth in the Needle-Free Drug Delivery Devices Market?

North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Needle-Free Drug Delivery Devices Market?

Needle-free drug delivery devices refer to medical tools designed to administer medication without traditional needles. They offer an alternative means of delivering drugs, vaccines, or therapeutic agents into the body through the skin or mucosal membranes. These devices aim to reduce patient discomfort and the risk of needle-related injuries.

Browse Through More Similar Reports By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: